Paper

Paper

Changelog Terms Privacy Issues Docs Support Foundation About

Epirubicin, oxaliplatin, and capecitabine with or without... | ResearchHub

Paper

Paper

Supporters

Support the authors with ResearchCoin

Journal

The Lancet Oncology

Topics

Cancer Oncology

Internal Medicine

Gastroenterology

DOI

10.1016/s1470-2045(13)70096-2

Changelog Terms Privacy Issues Docs Support Foundation About

Epirubicin, oxaliplatin, and capecitabine with or without panitumumab for patients with previously untreated advanced oesophagogastric cancer (REAL3): a randomised, open-label phase 3 trial

0

Authors

Thomas Waddell

Thomas Waddell•Andrew Wotherspoon•Yolanda Barbáchano

Published

April 17, 2013

Abstract

Supporters

Support the authors with ResearchCoin

Journal

The Lancet Oncology

Topics

Cancer Oncology

Internal Medicine

Gastroenterology

DOI

10.1016/s1470-2045(13)70096-2